Retinoid X receptor and c-erbA/thyroid hormone receptor regulate erythroid cell growth and differentiation

被引:25
作者
Bartunek, P [1 ]
Zenke, M [1 ]
机构
[1] Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany
关键词
D O I
10.1210/mend.12.9.0173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nuclear receptors are important regulators of erythroid cell development. Here we investigated the impact of retinoid X receptor (RXR), retinoic acid receptor (RAR), and of the c-erbA/thyroid hormone (T-3) receptor (c-erbA/TR) on growth and differentiation of erythroid cells using an in vitro culture system of stem cell factor-dependent erythroid progenitors. RXR, RAR, and c-erbA/TR-specific ligands were found to induce erythroid-specific gene expression and to accelerate erythroid differentiation in culture, with T-3 being most effective. Furthermore, while ligand-activated c-erbA/TR accelerated differentiation, unliganded c-erbA/TR effectively blocked differentiation and supported sustained progenitor growth in culture. Thus, c-erbA/TR appears to act as a binary switch affecting erythroid cell fate: unliganded c-erbA/TR supports growth while ligand-activated c-erbA/TR induces differentiation. Additionally, to determine the impact of RXR for erythroid cell development, dominant interfering mutant RXRs, lacking the transcriptional activator functions AF-1 and AF-2, or AF-2 only, or the entire DNA-binding domain, were introduced into erythroid progenitor cells via recombinant retrovirus vectors and analyzed for RXR-specific effects. It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells. In marked contrast, expression of the dominant interfering Delta DNA-binding domain RXR, containing a deletion of the entire DNA-binding domain, was incompatible with erythroid cell growth in vitro, suggesting a pivotal role of RXR for erythroid cell development.
引用
收藏
页码:1269 / 1279
页数:11
相关论文
共 63 条
  • [1] THE TAU-4 ACTIVATION DOMAIN OF THE THYROID-HORMONE RECEPTOR IS REQUIRED FOR RELEASE OF A PUTATIVE COREPRESSOR(S) NECESSARY FOR TRANSCRIPTIONAL SILENCING
    BANIAHMAD, A
    LENG, XH
    BURRIS, TP
    TSAI, SY
    TSAI, MJ
    OMALLEY, BW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (01) : 76 - 86
  • [2] A TRANSFERABLE SILENCING DOMAIN IS PRESENT IN THE THYROID-HORMONE RECEPTOR, IN THE V-ERBA ONCOGENE PRODUCT AND IN THE RETINOIC ACID RECEPTOR
    BANIAHMAD, A
    KOHNE, AC
    RENKAWITZ, R
    [J]. EMBO JOURNAL, 1992, 11 (03) : 1015 - 1023
  • [3] UNLIGANDED T3R, BUT NOT ITS ONCOGENIC VARIANT, V-ERBA, SUPPRESSES RAR-DEPENDENT TRANSACTIVATION BY TITRATING OUT RXR
    BARETTINO, D
    BUGGE, TH
    BARTUNEK, P
    RUIZ, MDMV
    SONNTAGBUCK, V
    BEUG, H
    ZENKE, M
    STUNNENBERG, HG
    [J]. EMBO JOURNAL, 1993, 12 (04) : 1343 - 1354
  • [4] Avian stem cell factor (SCF): Production and characterization of the recombinant His-tagged SCF of chicken and its neutralizing antibody
    Bartunek, P
    Pichlikova, L
    Stengl, G
    Boehmelt, G
    Martin, FH
    Beug, H
    Dvorak, M
    Zenke, M
    [J]. CYTOKINE, 1996, 8 (01) : 14 - 20
  • [5] The Myb leucine zipper is essential for leukemogenicity of the v-Myb protein
    Bartunek, P
    Karafiat, V
    Dvorakova, M
    Zahorova, V
    Mandikova, S
    Zenke, M
    Dvorak, M
    [J]. ONCOGENE, 1997, 15 (24) : 2939 - 2949
  • [6] CLONING AND NUCLEOTIDE-SEQUENCE OF THE 5' PART OF V-MYB CDNA
    BARTUNEK, P
    KOZMIK, Z
    DVORAK, M
    [J]. VIROLOGY, 1992, 190 (02) : 882 - 883
  • [7] Mechanism of transformation by v-ErbA: Substitution for steroid hormone receptor function in self renewal induction
    Bauer, A
    Ulrich, E
    Andersson, M
    Beug, H
    vonLindern, M
    [J]. ONCOGENE, 1997, 15 (06) : 701 - 715
  • [8] INSIGHTS INTO ERYTHROID-DIFFERENTIATION OBTAINED FROM STUDIES ON AVIAN ERYTHROBLASTOSIS VIRUS
    BEUG, H
    MULLNER, EW
    HAYMAN, MJ
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (06) : 816 - 824
  • [9] BEUG H, 1995, METHOD ENZYMOL, V254, P41
  • [10] BEUG H, 1992, NUCLEAR PROCESSES ON, P53